Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer

Technology appraisal guidance
Reference number: TA403
Published: 24 August 2016

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 166 KB)

Published:

31 August 2016

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 356 KB)

Published:

07 July 2016
Committee papers (PDF 991 KB)

Published:

07 July 2016

Draft guidance: 1

Draft guidance: 1
Committee papers (PDF 9.39 MB)

Published:

22 April 2016
Appraisal consultation document (PDF 360 KB)

Published:

22 April 2016
Committee papers (PDF 9.39 MB)

Published:

22 April 2016

Draft scope documents

Final scope (PDF 107 KB)

Published:

19 October 2015
Final matrix (PDF 175 KB)

Published:

19 October 2015
NICE's response to comments on the draft scope and provisional matrix (PDF 166 KB)

Published:

19 October 2015
Equality impact assessment (Scoping) (PDF 63 KB)

Published:

19 October 2015

Draft scope for consultation (pre-referral) - May 2015

Draft scope for consultation (pre-referral) - May 2015 (PDF 113 KB)

Published:

11 September 2015

Provisional matrix (pre-referral) - June 2015

Provisional matrix (pre-referral) - June 2015 (PDF 176 KB)

Published:

11 September 2015